FreeIn the Archives Cancer researchers, including Nobel laureates, center directors, gather at Nixon Library to mark 50th anniversary of the National Cancer Act November 19, 2021Vol.47 No.43
FreeHealth Equity Project Equity: FDA considers options to increase diverse enrollment in clinical trials November 12, 2021Vol.47 No.42By Matthew Bin Han Ong
Conversation with The Cancer LetterFreeHealth Equity FDA’s Lola Fashoyin-Aje: Stop getting stuck on the “risks” of diversity in drug development, it’s time to fix disparities in access November 12, 2021Vol.47 No.42By Matthew Bin Han Ong
Conversation with The Cancer LetterFreeHealth Equity NCTN group chairs, experts: Diverse representation of minorities in clinical trials and drug development saves lives November 12, 2021Vol.47 No.42By Matthew Bin Han Ong
FreeObituary Walter Lawrence, cancer surgeon and civil rights hero, dies at 96 November 12, 2021Vol.47 No.42By Robert A. Winn and Gordon D. Ginder
FreeIn the Archives The National Cancer Act pioneers: The Roswell Park hearings and VCU Massey’s Walter Lawrence November 12, 2021Vol.47 No.42
FreeHealth Equity Caryn Lerman’s AACI presidential initiative: Close the diversity gap in the cancer centers’ workforce November 05, 2021Vol.47 No.41By Matthew Bin Han Ong
Cancer History ProjectFreeNCI Sharpless: It’s time to confront the current reality of cancer and unravel it November 05, 2021Vol.47 No.41By Alice Tracey
FreeObituary Elihu H. Estey: Leukemia expert, statistician, gentle soul and friend November 05, 2021Vol.47 No.41By Roland B. Walter, Andreas Hochhaus and Robert Peter Gale
FreeObituary Edmund Gehan, creator of the “rule of 14” and the Wilcoxon-Gehan test, dies at 92 November 05, 2021Vol.47 No.41By Becky Slack Tidwell, J. Jack Lee, John Hanfelt and Donald A. Berry